Used as a key intermediate in the synthesis of Toll-like receptor 8 (TLR8) agonists, this compound plays an important role in immunomodulatory drug development. Its structure enables selective activation of TLR8, making it valuable in research for cancer immunotherapies and vaccine adjuvants. The chiral center contributes to enhanced biological activity and specificity, allowing lower effective doses in preclinical studies. It is primarily utilized in controlled laboratory settings for optimizing potency and reducing off-target effects in novel therapeutic candidates.